Dong-A Socio Holdings Co Ltd - Company Profile

Powered by

All the data and insights you need on Dong-A Socio Holdings Co Ltd in one report.

  • Save hours of research time and resources with
    our up-to-date Dong-A Socio Holdings Co Ltd Strategy Report

  • Understand Dong-A Socio Holdings Co Ltd position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Dong-A Socio Holdings Co Ltd: Overview

Dong-A Socio Holdings Co Ltd (Dong-A Socio Holdings), formerly Dong-A Pharmaceutical Co., Ltd, a subsidiary of Dong-A Socio Group that offers business management services. It operates in various markets such as pharmaceuticals, food and beverages, logistics, IT, and materials. The group focuses on new business investments, APIs, OTC products, consumer goods, prescription drugs, development of biomedicines, and research and development of new innovative drugs. Its major products include quasi-drug, Bacchus; a cold medicine, Anti-inflammatory, Antipyretic, Analgesic Drug, namely, Panpyrin-T, Panpyrin Q; Morning Care; a tampon; contraceptive medicine such as Myvlar; among others. Dong-A Socio Holdings is headquartered in Seoul, South Korea.

Gain a 360-degree view of Dong-A Socio Holdings Co Ltd and make more informed decisions for your business Gain a 360-degree view of Dong-A Socio Holdings Co Ltd and make more informed decisions for your business Find out more
Headquarters South Korea

Address 64, Cheonho-Daero, Dongdaemun-Gu, Seoul, 02587


Telephone 82 2 9208114

No of Employees 273

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange 000640 (KRX)

Revenue (2022) $867.1M 11.5% (2022 vs 2021)

EPS XYZ

Net Income (2022) XYZ 420% (2022 vs 2021)

Market Cap* $519.1M

Net Profit Margin (2022) XYZ 365.5% (2022 vs 2021)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Dong-A Socio Holdings Co Ltd premium industry data and analytics

230+

Clinical Trials

Determine Dong-A Socio Holdings Co Ltd go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

150+

Marketed Drugs

Understand Dong-A Socio Holdings Co Ltd’s commercialized product portfolio to stay one step ahead of the market.

90+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Dong-A Socio Holdings Co Ltd’s relevant decision makers and contact details.

90+

Catalyst Calendar

Proactively evaluate Dong-A Socio Holdings Co Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

70+

Pipeline Drugs

Identify which of Dong-A Socio Holdings Co Ltd’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

30+

Sales & Consensus Forecasts

Understand the current and future drug revenue for Dong-A Socio Holdings Co Ltd and assess market opportunity for new entrants with patient population 8-year forecasts.

6

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

4

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

Products and Services

Products Brands
Prescription Drugs: Panpyrin
Anti-Cancer Circulan
Anti-Fungal Bigen Cream Tone
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Dong-A Socio Holdings Co Ltd portfolio and identify potential areas for collaboration Understand Dong-A Socio Holdings Co Ltd portfolio and identify potential areas for collaboration Find out more
Image for loader

Competitor Comparison

Key Parameters Dong-A Socio Holdings Co Ltd Bayer Yakuhin Ltd SeouLin Bioscience Co Ltd PharmaResearch Bio Co Ltd Oscotec Inc
Headquarters South Korea Japan South Korea South Korea South Korea
City Seoul Kita-Ku Seongnam Gangneung Seongnam
State/Province - Osaka - - -
No. of Employees 273 2,554 88 78 35
Entity Type Public Private Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Shin-Ho Kang Chairman Executive Board - -
Jae Hun Jung Chief Executive Officer; Director; Vice President Executive Board - -
Seung-Hyun Ko Chief Financial Officer; Director - Finance Executive Board 2021 -
Min-Woo Jo Director - Executive Executive Board 2023 -
Young Sam Keum Director Non Executive Board - -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Dong-A Socio Holdings Co Ltd key executives to enhance your sales strategy Gain insight into Dong-A Socio Holdings Co Ltd key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward